Nascimento de Lima Pedro, Maerzluft Christopher, Ozik Jonathan, Collier Nicholson, Rutter Carolyn M
Engineering and Applied Sciences Department, RAND Corporation, Arlington, VA, USA.
Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Med Decis Making. 2025 Jul;45(5):557-568. doi: 10.1177/0272989X251334373. Epub 2025 Apr 29.
PurposeThe 2023 American College of Physicians (ACP) guidelines for colorectal cancer (CRC) screening are at odds with the United States Preventive Task Force (USPSTF) guidelines, with the former recommending screening starting at age 50 y and the latter at age 45 y. This article "stress tests" CRC colonoscopy screening strategies to investigate their robustness to uncertainties stemming from the natural history of disease and sensitivity of colonoscopy.MethodsThis study uses the CRC-SPIN microsimulation model to project the life-years gained (LYG) under several colonoscopy CRC screening strategies. The model was extended to include birth cohort effects on adenoma risk. We estimated natural history parameters under 2 different assumptions about the youngest age of adenoma initiation. For each, we generated 500 parameter sets to reflect uncertainty in the natural history parameters. We simulated 26 colonoscopy screening strategies and examined 4 different colonoscopy sensitivity assumptions, encompassing the range of sensitivities consistent with prior tandem colonoscopy studies. Across this set of scenarios, we identify efficient screening strategies and report posterior credible intervals for benefits of screening (LYG), burden (number of colonoscopies), and incremental burden-effectiveness ratios.ResultsProjected absolute screening benefits varied widely based on assumptions, but strategies starting at age 45 y were consistently in the efficiency frontier. Strategies in which screening starts at age 50 y with 10-y intervals were never efficient, saving fewer life-years than starting screening at age 45 y and performing colonoscopies every 15 y while requiring more colonoscopies per person.ConclusionsDecennial colonoscopy screening initiation at age 45 y remained a robust recommendation. Colonoscopy screening with a 10-y interval starting at age 50 y did not result in an efficient use of colonoscopies in any of the scenarios evaluated.HighlightsColorectal cancer colonoscopy screening strategies initiated at age 45 y were projected to yield more life-years gained while requiring the least number of colonoscopies across different model assumptions about disease natural history and colonoscopy sensitivity.Colonoscopy screening starting at age 50 y with a 10-y interval consistently underperformed strategies that started at age 45 y.
目的
2023年美国医师协会(ACP)的结直肠癌(CRC)筛查指南与美国预防服务工作组(USPSTF)的指南不一致,前者建议从50岁开始筛查,而后者建议从45岁开始。本文对CRC结肠镜筛查策略进行“压力测试”,以研究其对疾病自然史和结肠镜敏感性所产生的不确定性的稳健性。
方法
本研究使用CRC-SPIN微观模拟模型来预测几种结肠镜CRC筛查策略下获得的生命年数(LYG)。该模型进行了扩展,以纳入出生队列对腺瘤风险的影响。我们在关于腺瘤起始最小年龄的2种不同假设下估计自然史参数。对于每种假设,我们生成500个参数集以反映自然史参数的不确定性。我们模拟了26种结肠镜筛查策略,并检查了4种不同的结肠镜敏感性假设,涵盖了与先前串联结肠镜研究一致的敏感性范围。在这组情景中,我们确定有效的筛查策略,并报告筛查益处(LYG)、负担(结肠镜检查次数)和增量负担效益比的后验可信区间。
结果
根据假设,预计的绝对筛查益处差异很大,但从45岁开始的策略始终处于效率前沿。从50岁开始每10年进行一次筛查的策略从未有效过,与从45岁开始筛查且每15年进行一次结肠镜检查相比,挽救的生命年数更少,同时每人需要的结肠镜检查更多。
结论
45岁开始每10年进行一次结肠镜筛查仍然是一个稳健的建议。在评估的任何情景中,50岁开始每10年进行一次结肠镜筛查都没有有效利用结肠镜检查。
要点
预计从45岁开始的结直肠癌结肠镜筛查策略在不同的疾病自然史和结肠镜敏感性模型假设下,能获得更多生命年,同时所需的结肠镜检查次数最少。
从50岁开始每10年进行一次结肠镜筛查的策略始终不如从45岁开始的策略。